Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03263390 · ClinicalTrials.gov registry record
Modeling the Neurological Basis and Characterizing the Neurological Phenotype of Obesity Using Human Neural Stem Cells
A clinical trial, sponsored by University of California, San Diego.
- Terminated
- Registry status
- 6
- Enrollment target
NCT03263390 is a clinical trial that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 6 participants.
The verdict
NCT03263390 was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This study aims to characterize the neurological basis of obesity and response to surgical and medical treatment by inducing adult pluripotent stem cells into neuronal cells from subjects that have demonstrated extreme response to bariatric surgery or pharmacological treatment for obesity.
Interventions
- PROCEDURE Bariatric Surgery
- DRUG Anti Obesity Drugs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-10-05 |
| Est. Completion | 2020-08-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03263390
The ClinicalTrials.gov registry entry for NCT03263390 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bariatric Surgery is the first listed.
NCT03263390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03263390 about?
NCT03263390 is a clinical study titled "Modeling the Neurological Basis and Characterizing the Neurological Phenotype of Obesity Using Human Neural Stem Cells". This study aims to characterize the neurological basis of obesity and response to surgical and medical treatment by inducing adult pluripotent stem cells into neuronal cells from subjects that have demonstrated extreme response to bariatric surgery or pharmacological treatment for obesity.
What is the current status of trial NCT03263390?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2017-10-05. Estimated completion is 2020-08-10.
What interventions are being tested in trial NCT03263390?
The interventions under investigation include: Bariatric Surgery (PROCEDURE), Anti Obesity Drugs (DRUG).
Who is sponsoring clinical trial NCT03263390?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.